Global Nuclear Imaging Market 2015-2019
|出版商||TechNavio (Infiniti Research Ltd.)||商品編碼||325829|
|出版日期||內容資訊||英文 106 Pages
|核子醫學攝影的全球市場:2015年∼2019年 Global Nuclear Imaging Market 2015-2019|
|出版日期: 2015年03月11日||內容資訊: 英文 106 Pages||
Nuclear imaging is a non-invasive procedure used to diagnose and treat various diseases such as cancer, heart diseases, and brain disorders. In this procedure, radioactive substances are used to provide a detailed image of the body at the molecular as well as the cellular level. A small amount of the radioactive particle is taken internally, orally or intravenously. External detectors such as gamma cameras then work with a computer to provide a precise image of the body. Nuclear imaging helps determine the severity of diseases and disease progression, in selecting effective therapy based on the biologic character of the body, and determining the patient's response to a particular drug.
TechNavio's analysts forecast the Global Nuclear Imaging market to grow at a CAGR of 5.89 percent over the period 2014-2019.
The Global Nuclear Imaging market can be segmented into the revenue generated from the following segment such as SPECT and PET
TechNavio's report, Global Nuclear Imaging market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Nuclear Imaging market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.